SCHEMBL28699130

SCHEMBL28699130

CC(C)=CCC1CC(=O)c2ccccc2O1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.50
ABCB1 P08183 3/20 0.48
SIGMAR1 Q99720 2/20 0.48
MAOB P27338 4/20 0.48
ADORA3 P0DMS8 3/20 0.48
AR P10275 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 2/20 0.46
MAPT P10636 2/20 0.46
RAB9A P51151 2/20 0.46
HSD11B1 P28845 1/20 0.46
AKR1C3 P42330 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPK1 P28482 1/20 0.46
HTR1A P08908 1/20 0.45
AXL P30530 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8873822 0.82 MAOB (0.53) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL8596185 0.82 MAOB (0.53) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL8874261 0.81 ABCB1 (0.49) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL8598021 0.81 ABCB1 (0.49) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL8598023 0.81 ABCB1 (0.49) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL6920340 0.81 MAOB (0.51) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL28390611 0.79 HRH3 (0.46) CYP19A1MAOBHTR1A
SCHEMBL23662356 0.79 MAOB (0.56) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL6828123 0.79 MAOB (0.56) CYP19A1ABCB1SIGMAR1MAOBADORA3
SCHEMBL6746035 0.79 MAOB (0.56) CYP19A1ABCB1SIGMAR1MAOBADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113979982-A Preparation method and application of chiral dihydrochromone-2-carboxylic acid compound and derivative thereof 中国人民解放军空军军医大学 2022-01-28 CN disclosed